论文部分内容阅读
目的 :探讨视网膜静脉周围炎合并玻璃体积血进行玻璃体切除手术治疗的时机。方法 :对 3 7例 ( 4 2眼 )视网膜静脉周围炎合并玻璃体积血进行玻璃体切除术治疗的患者进行回顾性分析 ,按术前玻璃体出血时间分成三组 ,对各组玻璃体视网膜病变程度及手术经过、术后并发症、术后视力恢复情况进行比较分析。结果 :出血时间小于 3个月的 ,其玻璃体视网膜病变的程度明显轻于出血时间大于 3个月组及大于 6个月组。术后并发症以术前出血时间大于 6个月组最高。术后视力 >0 .3者 ,以出血时间小于 3个月组的百分率最高 ,达 60 % ,明显优于出血时间大于 6个月组 ( 13 % )。结论 :对于视网膜静脉周围炎玻璃体积血在药物治疗 2个月无吸收 ,有玻璃体增殖性改变者 ,应尽早行玻璃体切除术 +激光光凝治疗。
Objective: To investigate the timing of vitrectomy for periprocedural inflammation with vitreous hemorrhage. Methods: A total of 37 patients (42 eyes) with vitreous hemorrhage and vitreous hemorrhage were retrospectively analyzed. The preoperative vitreous hemorrhage time was divided into three groups. The degree of vitreoretinopathy After, postoperative complications, postoperative visual acuity recovery comparative analysis. Results: Bleeding time less than 3 months, the degree of vitreoretinal lesions was significantly lighter than the bleeding time of more than 3 months and more than 6 months group. Postoperative complications with preoperative bleeding time was greater than the 6-month group was the highest. Postoperative visual acuity> 0.3, the bleeding rate of less than 3 months the highest percentage of 60%, significantly better than the bleeding time of more than 6 months (13%). Conclusion: For vitreous hemorrhage of retinal vein inflammation in the medication for 2 months without absorption, there are changes in vitreous proliferative vitrectomy should be performed as soon as possible laser photocoagulation treatment.